BioWorld12h
Solventum sells $4.1B purification unit to Thermo Fisher
The trend of corporate pruning in med tech continues with Solventum Corp.’s decision to sell its purification and filtration business to Thermo Fisher Scientific Inc. for $4.1 billion. The ...
BioWorld12h
Regeneron gene therapy improves children’s hearing
In Regeneron Pharmaceuticals Inc.’s phase I/II Chord study of 12 children with genetic hearing loss, 10 out of 11 have shown improvements after being treated with a gene therapy. “What is really ...
BioWorld12h
Kyorin drafts deals for chronic cough DTx, loss of smell therapy
Kyorin Pharmaceutical Co. Ltd. struck two licensing deals recently, including one with Hyfe Inc. Feb. 25 to develop the world ...
BioWorld19h
In multiple sclerosis, deep cervical lymph nodes show an EBV-like pattern
Epstein-Barr virus (EBV) infection is a recognized risk factor that is now regarded as a prerequisite for the development of ...
BioWorld1d
US lawmakers tell Kennedy: No more ‘indiscriminate’ terminations
Citing recent executive orders that suggest additional cuts to the federal workforce may be in the offing, U.S. Sens. Patty Murray, D-Wash., and Jeanne Shaheen, D-N.H., wrote to Health and Human ...
BioWorld1d
Pepgen rallies as early data suggest sporting chance in DM1
Pepgen Inc. seems to have gained a leg up on competitors in early data with PGN-EDODM1 in myotonic dystrophy type 1 (DM1), ...
BioWorld1d
Eliminating redundancies opens up possibilities for protein engineering
Researchers have altered the genetic code in a strain of Escherichia coli, reducing the number of stop codons from three to one and assigning the freed-up stop codons to nonstandard amino acids. They ...
BioWorld2d
Berlin Heals raises funds for device to reverse heart failure
Berlin Heals Holding AG recently raised over CHF7 million (US$7.8 million) in a financing round for C-MIC, a small ...
BioWorld2d
BioWorld Insider Podcast: Mega money well spent? Mammoth mergers fall short of the dream
Billion-dollar M&As are commonplace now, but not too long ago they were a rarity. So many have occurred in the past few years, they’ve become the norm. But were all these multi-billion-dollar mega ...
BioWorld2d
Infectious disease index recovers from -25% low, ends 2024 down 6.28%
The BioWorld Infectious Disease Index (BIDI) faced challenges throughout the year but narrowed its losses, ending down 6.28% after hitting a low of -25.12% in late April. By October, the index was ...
BioWorld2d
Cosette paying $430M for Mayne's women’s health, dermatology franchise
Cosette Pharmaceuticals Inc. announced plans to acquire Adelaide, Australia-based Mayne Pharma Pty Ltd. for AU$672 million (US$430 million) to grow its women’s health and dermatology franchise in the ...
BioWorld2d
US FDA clears Sonio Suspect for fetal anomaly detection
The U.S. FDA hasn’t taken up criminal justice as a sideline, but it did just clear Sonio Suspect. Far from a social miscreant, Suspect improves detection of fetal anomalies by 22 points by ...